ACROBiosystems, a global cornerstone of the pharmaceutical industry committed to offering innovative tools and solutions, announces the launch of GMP grade DLL4. GMP grade DLL4 is the first recombinant Delta-like Ligand 4, or DLL4, to be launched on the market under GMP conditions. The availability of DLL4 manufactured under GMP conditions represents a significant milestone […]
Research Triangle Park, a North Carolina technology and biotech hub, is Donaldson’s choice for the latest expansion of its life sciences footprint MINNEAPOLIS — Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, announced its commitment to broadening its life sciences reach with the opening of a 25,000-square-foot life […]
World-class liquid biopsy testing will be made commercially available to BioReference® customers across the country BOSTON MA, ELMWOOD PARK, NJ, and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that processes more than 12 million tests annually, […]
New Partnership to Advance Data, Enhance Disease Detection and Care in Diverse Communities BRONX, NY — The New York Center for Rare Diseases (NYCRD) at Montefiore, recognized as a Center of Excellence by the National Organization for Rare Disorders (NORD), is partnering with GeneDx, PacBio and Google Health to deliver genetic diagnoses for Bronx families living with […]
Life science firms join forces to deliver better, faster, more accurate testing results. As the leader in pathogen detection technology and genomic analysis and interpretation, we’re constantly looking for ways to make our customers’ businesses run smoother and more profitably.” — Brendan McKernan, MGC CEO BEVERLY, MA, USA — Medicinal Genomics Corp. (MGC), a pioneer in harnessing genomics […]
REHOVOT, Israel — Sequentify, a Weizmann Institute spinoff that develops synthetic biology and AI software to enable rapid targeted DNA sequencing, is pleased to announce Stanford Institute for Stem Cell Biology and Regenerative Medicine will be using its NGS targeted panels for acute myeloid leukemia (AML) somatic mutation detection. Applications include basic and translational research into AML pathogenesis […]
Non-infectious TiterSafe particles can be used as a virus substitute in hemagglutination inhibition (HAI) assays to test influenza vaccine efficacy. Philadelphia – Integral Molecular, a leading provider of reagents for vaccine evaluation, announces the launch of TiterSafe™ influenza virus-like particles, an off-the-shelf virus-alternative for key experiments in testing influenza vaccines. Titersafe is a safe and convenient […]
Greg Herrema to Spearhead Next Phase of Global Biospecimen and Biomarker Company’s Expansion HUNTSVILLE, Ala. — Discovery Life Sciences, the Biospecimen and Biomarker Specialists, announced today the appointment of Greg Herrema as its new chief executive officer. A leader with more than 20 years of experience across the life sciences and industrial sectors, Mr. Herrema […]
Agreement is part of Veracyte’s multi-platform strategy for its decentralized IVD tests outside of the U.S. SOUTH SAN FRANCISCO, Calif. — Veracyte, Inc. (Nasdaq: VCYT) today announced that it has entered into a multi-year agreement with Illumina, Inc. (Nasdaq: ILMN) to develop and offer some of its high-performing molecular tests as decentralized in vitro diagnostic (IVD) tests on Illumina’s NextSeq […]
SAN DIEGO, Calif. — VedaBio, the biotechnology company leading a paradigm-shift in molecular detection, today announced the formation of its scientific advisory board (SAB) comprised of world class academic and industry experts Rashid Bashir, PhD, Daniel Durocher, PhD, Patrick Hsu, PhD and David Perlin, PhD. VedaBio launched in October with initial funding of over $40 Million backed […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
